- $438.66m
- $445.98m
- $99.99m
Brief: Neuropace Receives IDE Approval To Initiate NAUTILUS Pivotal Study Of Its RNS System
Brief: Neuropace Announces Addition Of Lisa Andrade To The Board
Neuropace Inc reports results for the quarter ended in June - Earnings Summary
NeuroPace rises on NIH grant to test device in childhood-onset epilepsy
Brief: Neuropace Awarded Five-Year NIH Grant Funding Of More Than $9 Mln
U.S. RESEARCH ROUNDUP-Benefitfocus, Constellation Pharmaceuticals, Redfin
Neuropace Inc reports results for the quarter ended in March - Earnings Summary
U.S. RESEARCH ROUNDUP- Amgen, Lion Electric, UiPath
U.S. STOCKS ON THE MOVE-Airlines, alternative energy stocks, Fisker Coinbase
NeuroPace pops after pricing upsized IPO
Brief: Neuropace Inc Shares Open 36.8% Above IPO Price In Nasdaq Debut
NASDAQ RESUMED AT 12:05 PM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM